Document:

EX-10.32

 Exhibit 10.32 

INDEMNIFICATION AGREEMENT 

This Indemnification Agreement (“Agreement”) is made as of             
    , 20     by and between Virgin America Inc., a Delaware corporation (the “Company”), and
                     (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and
Indemnitee covering the subject matter of this Agreement except as otherwise provided herein. 
 RECITALS 

WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors or in other capacities unless
they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation; 

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary
and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at higher premiums and
with more exclusions. At the same time, directors, officers, substantial stockholders and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among
other things, matters that traditionally would have been brought only against the Company or business enterprise itself. The Amended and Restated Bylaws of the Company (the “By-laws”) and the Tenth Amended and Restated Certificate of
Incorporation (the “Certificate of Incorporation”) require indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware
(the “DGCL”). Each of the By-laws, Certificate of Incorporation and the DGCL expressly provides that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the
Company and members of the board of directors, officers and other persons with respect to indemnification; 
 WHEREAS, the uncertainties
relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons; 
 WHEREAS, the
Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company and its stockholders and that the Company should act to assure such persons that there will be increased
certainty of such protection in the future; 
 WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate
itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified; 

 WHEREAS, this Agreement is a supplement to and in furtherance of the DGCL, the By-laws,
Certificate of Incorporation and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; and 

WHEREAS, Indemnitee does not regard the protection available under the DGCL, the By-laws, Certificate of Incorporation and insurance as
adequate in the present circumstances, and may not be willing to serve as an officer or director without adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take
on additional service for or on behalf of the Company on the condition that he be so indemnified. 
 NOW, THEREFORE, in consideration of the
premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows: 
 Section 1.
Services to the Company. Indemnitee agrees to serve as a director of the Company. Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of
law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee in such position. This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and
Indemnitee. Indemnitee specifically acknowledges that Indemnitee’s employment with the Company (or any of its subsidiaries or any Enterprise), if any, is at will, and the Indemnitee may be discharged at any time for any reason, with or without
cause, except as may be otherwise provided in any written employment contract between Indemnitee and the Company (or any of its subsidiaries or any Enterprise), other applicable formal severance policies duly adopted by the Board, or, with respect
to service as a director or officer of the Company, by the Certificate of Incorporation, the Company’s By-laws, and the DGCL. The foregoing notwithstanding, this Agreement shall continue in force after Indemnitee has ceased to serve as a
director of the Company, as provided in Section 16 hereof. 
 Section 2. Definitions. As used in this Agreement: 

(a) References to “agent” shall mean any person who is or was a director, officer, or employee of the Company or a subsidiary of the
Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, fiduciary or other official of another corporation, partnership, limited liability company,
joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company. 

  
 -2- 

 (b) A “Change in Control” shall be deemed to occur upon the earliest to occur after the
date of this Agreement of any of the following events: 
 i. Acquisition of Stock by Third Party. Any Person (as defined below), other than
a Designating Stockholder, is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then
outstanding securities, or a Designating Stockholder becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding
securities, unless the change in relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of
directors; 
 ii. Change in Board of Directors. During any period of two (2) consecutive years (not including any period prior to the
execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction
described in Sections 2(b)(i), 2(b)(iii) or 2(b)(iv)) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were
directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board; 

iii. Corporate Transactions. The effective date of a merger or consolidation of the Company with any other entity, other than a merger or
consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the
surviving entity) more than 51% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or
other governing body of such surviving entity; 
 iv. Liquidation. The approval by the stockholders of the Company of a complete
liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets; and 

v. Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A
of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement. 

For purposes of this Section 2(b), the following terms shall have the following meanings: 

(A) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time. 

  
 -3- 

 (B) “Person” shall have the meaning as set forth in Sections 13(d) and
14(d) of the Exchange Act; provided, however, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any corporation owned, directly
or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. 

(C) “Beneficial Owner” shall have the meaning given to such term in Rule 13d-3 under the Exchange Act; provided,
however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity. 

(c) “Corporate Status” describes the status of a person who is or was a director, trustee, partner, managing member, officer,
employee, agent or fiduciary of the Company or of any other corporation, limited liability company, partnership or joint venture, trust or other enterprise which such person is or was serving at the request of the Company. 

(d) “Designating Stockholder” shall mean Virgin Group Holdings Limited so long as an individual designated (directly or indirectly)
by Virgin Group Holdings Limited or any of its affiliates serves as a director of the Company and Cyrus Aviation Holdings, LLC so long as an individual who is a director, officer or employee of, or who is otherwise affiliated with, Cyrus Aviation
Holdings, LLC serves as a director of the Company. 
 (e) “Disinterested Director” shall mean a director of the Company who is not
and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. 
 (f) “Enterprise” shall mean
the Company and any other corporation, limited liability company, partnership, joint venture, trust or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, partner, managing member,
employee, agent or fiduciary. 
 (g) “Expenses” shall include all reasonable attorneys’ fees, retainers, court costs,
transcript costs, fees of experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services, any federal,
state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties, and all other disbursements, obligations or expenses of the types customarily
incurred in connection with, or as a result of, prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a deponent or witness in, or otherwise participating in, a Proceeding. Expenses also shall include
(i) Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the 

  
 -4- 

 
premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, (ii) expenses incurred in connection with recovery under any
directors’ and officers’ liability insurance policies maintained by the Company, regardless of whether the Indemnitee is ultimately determined to be entitled to such indemnification, advancement or Expenses or insurance recovery, as the
case may be, and (iii) for purposes of Section 15(d) only, Expenses incurred by or on behalf of Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement, by litigation or
otherwise. The parties agree that for the purposes of any advancement of Expenses for which Indemnitee has made written demand to the Company in accordance with this Agreement, all Expenses included in such demand that are certified by affidavit of
Indemnitee’s counsel as being reasonable shall be presumed conclusively to be reasonable. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. 

(h) “Independent Counsel” shall mean a law firm, or a member of a law firm, that is experienced in matters of corporation law and
neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or
of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not
include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this
Agreement. The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this
Agreement or its engagement pursuant hereto. 
 (i) The term “Proceeding” shall include any threatened, pending or completed
action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of
the Company or otherwise and whether of a civil, criminal, administrative, regulatory, legislative, or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is, may be or will be involved as a party,
potential party, non-party witness or otherwise by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action taken by him (or a failure to take action by him) or of any action (or failure to act) on
his part while acting pursuant to his Corporate Status, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification, reimbursement, or advancement of Expenses can be provided under
this Agreement. If the Indemnitee believes in good faith that a given situation may lead to or culminate in the institution of a Proceeding, such situation shall be considered a Proceeding under this paragraph. 

  
 -5- 

 (j) Reference to “other enterprise” shall include employee benefit plans; references to
“fines” shall include any excise tax assessed with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any service as a director, officer, employee or agent of the Company
which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to
be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in manner “not opposed to the best interests of the Company” as referred to in this Agreement. 

Section 3. Indemnity in Third-Party Proceedings. The Company shall indemnify Indemnitee in accordance with the provisions of this
Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee
shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of
such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a
manner he reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause to believe that his conduct was unlawful. The parties hereto intend that this Agreement
shall provide to the fullest extent permitted by law for indemnification in excess of that expressly permitted by statute, including, without limitation, any indemnification provided by the Certificate of Incorporation, the By-laws, vote of its
stockholders or disinterested directors or applicable law. 
 Section 4. Indemnity in Proceedings by or in the Right of the
Company. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a
judgment in its favor. Pursuant to this Section 4, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by him or on his behalf in connection with such
Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. No indemnification for Expenses shall be made under this
Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that the Delaware Court or any court in which the Proceeding was
brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such indemnification may be made. 

Section 5. Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of
this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue

  
 -6- 

 
or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith. If Indemnitee is not wholly
successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably
incurred by him or on his behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by law. For purposes of this Section and without limitation, the termination of any claim, issue or
matter in such a Proceeding by dismissal, with or without prejudice, whether on substantive or procedural grounds shall be deemed to be a successful result as to such claim, issue or matter. 

Section 6. Indemnification of Designating Stockholder. If the Designating Stockholder or any affiliate of the Designating
Stockholder is, or is threatened to be made, a party to or a participant in any Proceeding relating to or arising by reason of the Designating Stockholder’s or any of its affiliates’ position as a stockholder of the Company or the
Designating Stockholder’s or any of its affiliates’ appointment of or affiliation with Indemnitee or any other Board member, then the Designating Stockholder and its affiliates will be entitled to indemnification hereunder to the same
extent as Indemnitee, and the terms of this Agreement as they relate to procedures for indemnification of Indemnitee and advancement of Expenses shall apply to any such indemnification of the Designating Stockholder and its affiliates. 

Section 7. Indemnification For Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the fullest extent
permitted by applicable law and to the extent that Indemnitee is, by reason of his Corporate Status, a witness or otherwise asked to participate in any aspect of a Proceeding to which Indemnitee is not a party, he shall be indemnified against all
Expenses actually and reasonably incurred by him or on his behalf in connection therewith. 
 Section 8. Partial
Indemnification. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify
Indemnitee for the portion thereof to which Indemnitee is entitled. 
 Section 9. Additional Indemnification. 

(a) Notwithstanding any limitation in Sections 3, 4 or 5, the Company shall indemnify Indemnitee to the fullest extent permitted by applicable
law if Indemnitee is a party to or threatened to be made a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines and amounts
paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by or on behalf of
Indemnitee in connection with the Proceeding. 

  
 -7- 

 (b) For purposes of Section 9(a), the meaning of the phrase “to the fullest extent
permitted by applicable law” shall include, but not be limited to: 
 i. to the fullest extent permitted by the provision of the DGCL
that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL, and 

ii. to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement
that increase the extent to which a corporation may indemnify its officers and directors. 
 Section 10. Exclusions.
Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification payment in connection with any claim made against Indemnitee: 

(a) for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision of the
Company or its subsidiaries, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision of the Company or its subsidiaries; or 

(b) for (i) an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company
within the meaning of Section 16(b) of the Exchange Act (as defined in Section 2(b) hereof) or similar provisions of state statutory law or common law, or (ii) any reimbursement of the Company by the Indemnitee of any bonus or other
incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting
restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of
Section 306 of the Sarbanes-Oxley Act); or 
 (c) except as provided in Section 15(d) of this Agreement, in connection with any
Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the
Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, (ii) such payment arises in connection with any mandatory counterclaim or cross-claim or affirmative defense brought or raised by Indemnitee in any
Proceeding (or any part of any Proceeding), or (iii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law. 

Section 11. Advances of Expenses. Notwithstanding any provision of this Agreement to the contrary (other than Section 15(d)),
the Company shall advance promptly, to the extent not prohibited by law, the Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding (or any part of any Proceeding) not initiated by Indemnitee, and such advancement shall be
made, within thirty (30) days after the receipt by the Company of a statement or statements requesting such advances from time to time (which shall include invoices received by the Indemnitee in connection with such Expenses but, in the case of
invoices in connection with 

  
 -8- 

 
legal services, any references to legal work performed or to expenditures made that would cause Indemnitee to waive any privilege accorded by applicable law shall not be so included), whether
prior to or after final disposition of any Proceeding and such advancement shall continue until such time (if any) as there is a final non-appealable judicial determination that Indemnitee is not entitled to indemnification. Advances shall be
unsecured and interest free. Advances shall be made without regard to Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to indemnification under the other provisions of this Agreement. In
accordance with Section 15(d), advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support
the advances claimed. The Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking providing that the Indemnitee undertakes to repay the amounts advanced (without
interest) to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company. No other form of undertaking shall be required other than the execution of this Agreement. This Section 11 shall not
apply to any claim made by Indemnitee for which indemnity is excluded pursuant to Section 10. 
 Section 12. Procedure for
Notification and Defense of Claim. 
 (a) Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee
intends to seek indemnification or advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof or Indemnitee’s becoming aware thereof. The written notification to the Company
shall include a description of the nature of the Proceeding and the facts underlying the Proceeding, in each case to the extent known to Indemnitee. To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written
request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final
disposition of such Proceeding. The failure by Indemnitee to notify the Company hereunder will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay in so notifying
the Company shall not constitute a waiver by Indemnitee of any rights under this Agreement, except to the extent (solely with respect to the indemnity hereunder) that such failure or delay materially prejudices the Company. 

(b) The Company will be entitled to participate in the Proceeding at its own expense. 

(c) The Company shall not settle any Proceeding (in whole or in part) if such settlement would impose any Expense, judgment, liability, fine,
penalty or limitation on Indemnitee for which Indemnitee is not entitled to be indemnified by the Company hereunder without the Indemnitee’s prior written consent. 

  
 -9- 

 Section 13. Procedure Upon Application for Indemnification. 

(a) Upon written request by Indemnitee for indemnification pursuant to Section 12(a), a determination, if required by applicable law,
with respect to Indemnitee’s entitlement thereto shall be made in the specific case: (i) if a Change in Control shall have occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to
Indemnitee; or (ii) if a Change in Control shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a
majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board,
a copy of which shall be delivered to Indemnitee or (D) if so directed by the Board, by the stockholders of the Company; and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten
(10) days after such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity
upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or Expenses
(including attorneys’ fees and disbursements) incurred by or on behalf of Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to
Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. The Company promptly will advise Indemnitee in writing with respect to any determination that Indemnitee is or is
not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied. 
 (b) In the
event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 13(a) hereof, the Independent Counsel shall be selected as provided in this Section 13(b). If a Change in Control shall not
have occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to Indemnitee advising him of the identity of the Independent Counsel so selected. If a Change in Control shall have occurred, the
Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of
the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to
Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of
“Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as
Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such 

  
 -10- 

 
objection is withdrawn or the Delaware Court has determined that such objection is without merit. If, within twenty (20) days after the later of submission by Indemnitee of a written request
for indemnification pursuant to Section 12(a) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for
resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by such court or by such other person as
such court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 13(a) hereof. Upon the due commencement of any judicial proceeding or
arbitration pursuant to Section 15(a) of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). 

(c) If the Company disputes a portion of the amounts for which indemnification is requested, the undisputed portion shall be paid and only the
disputed portion withheld pending resolution of any such dispute. 
 Section 14. Presumptions and Effect of Certain Proceedings.

 (a) In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such
determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 12(a) of this
Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof and the burden of persuasion by clear and convincing evidence to overcome that presumption in connection with the making by any person, persons
or entity of any determination contrary to that presumption. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that
indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable
standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. 

(b) Subject to Section 15(e), if the person, persons or entity empowered or selected under Section 13 of this Agreement to determine
whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the
fullest extent not prohibited by law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make
Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law; provided, however, that such 60-day period may be

  
 -11- 

 
extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good
faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this Section 14(b) shall not apply (i) if the determination
of entitlement to indemnification is to be made by the stockholders pursuant to Section 13(a) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has
resolved to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of
stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made
thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) of this Agreement. 

(c) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea
of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in
good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful. 

(d) For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is
based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for
the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with the reasonable care by the Enterprise. The provisions of this
Section 14(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement. Whether or not the foregoing
provisions of this Section 14(d) are satisfied, it shall in any event be presumed that Indemnitee has at all times acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the Company. Anyone
seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. 
 (e)
The knowledge and/or actions, or failure to act, of any director, officer, trustee, partner, managing member, fiduciary, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification
under this Agreement. 

  
 -12- 

 Section 15. Remedies of Indemnitee. 

(a) Subject to Section 15(e), in the event that (i) a determination is made pursuant to Section 13 of this Agreement that
Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 11 of this Agreement, (iii) no determination of entitlement to indemnification shall have been
made pursuant to Section 13(a) of this Agreement within ninety (90) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Section 5, 6, 7 or 8 or the last
sentence of Section 13(a) of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) payment of indemnification pursuant to Section 3, 4 or 9 of this Agreement is not made within ten
(10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vi) in the event that the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable,
or institutes any litigation or other action or Proceeding designed to deny, or to recover from, the Indemnitee the benefits provided or intended to be provided to the Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by a court
of his entitlement to such indemnification or advancement of Expenses. Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American
Arbitration Association. Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this
Section 15(a); provided, however, that the foregoing clause shall not apply in respect of a proceeding brought by Indemnitee to enforce his rights under Section 5 of this Agreement. The Company shall not oppose
Indemnitee’s right to seek any such adjudication or award in arbitration. 
 (b) In the event that a determination shall have been made
pursuant to Section 13(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 15 shall be conducted in all respects as a de novo
trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 15 the Company shall have the burden of proving
Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be. 
 (c) If a determination shall have been made
pursuant to Section 13(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 15, absent (i) a
misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such
indemnification under applicable law. 
 (d) The Company shall, to the fullest extent not prohibited by law, be precluded from asserting in
any judicial proceeding or arbitration commenced pursuant to this Section 15 that the procedures and presumptions of this Agreement are not valid, binding and 

  
 -13- 

 
enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. It is the intent of the Company that, to the
fullest extent permitted by law, the Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement by litigation or otherwise because the
cost and expense thereof would substantially detract from the benefits intended to be extended to the Indemnitee hereunder. The Company shall, to the fullest extent permitted by law, indemnify Indemnitee against any and all Expenses and, if
requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefor) advance, to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by or on behalf of Indemnitee in
connection with any action brought by Indemnitee for indemnification or advancement of Expenses from the Company under this Agreement or under any directors’ and officers’ liability insurance policies maintained by the Company if, in the
case of indemnification, Indemnitee is wholly successful on the underlying claims; if Indemnitee is not wholly successful on the underlying claims, then such indemnification shall be only to the extent Indemnitee is successful on such underlying
claims or otherwise as permitted by law, whichever is greater. 
 (e) Notwithstanding anything in this Agreement to the contrary, no
determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding. 

Section 16. Non-exclusivity; Survival of Rights; Insurance; Subrogation. 

(a) The rights of indemnification and to receive advancement of Expenses as provided by this Agreement (i) shall not be deemed exclusive
of any other rights to which Indemnitee may at any time be entitled under applicable law, the Certificate of Incorporation, the By-laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise and (ii) shall be
interpreted independently of, and without reference to, any other such rights to which Indemnitee may at any time be entitled. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of
Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in Delaware law, whether by legislative act or judicial
decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the By-laws, Certificate of Incorporation and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this
Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and
remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

 (b) The Company shall maintain an insurance policy or policies providing liability insurance for directors, officers, employees, or
agents of the Enterprise and Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum 

  
 -14- 

 
extent of the coverage available for any such director, officer, employee or agent under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms
hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the insurers in accordance with the procedures set forth in
the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such
policies. 
 (c) The Company hereby acknowledges that Indemnitee has certain rights to indemnification, advancement of expenses and/or
insurance provided by the Designating Stockholder and certain of its affiliates (collectively, the “Stockholder Indemnitors”). The Company hereby agrees (i) that it is the Indemnitor of first resort (i.e., its obligations to
Indemnitee (which, for the avoidance of doubt, does not include the Stockholder Indemnitors) are primary and any obligation of the Stockholder Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by Indemnitee are secondary), (ii) that it shall be required to advance the full amount of expenses incurred by Indemnitee and shall be liable for the full amount of all Expenses, judgments, penalties, fines and amounts paid in
settlement to the extent legally permitted and as required by the terms of this Agreement and the Certificate of Incorporation or Bylaws of the Company (or any other agreement between the Company and Indemnitee), without regard to any rights
Indemnitee may have against the Stockholder Indemnitors and (iii) that it irrevocably waives, relinquishes and releases the Stockholder Indemnitors from any and all claims against the Stockholder Indemnitors for contribution, subrogation or any
other recovery of any kind in respect of amounts indemnified or advanced pursuant to sub-Sections 16(c)(i) and (ii) above. The Company further agrees that no advancement or payment by the Stockholder Indemnitors on behalf of Indemnitee with
respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the foregoing, and the Stockholder Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to
all of the rights of recovery of Indemnitee against the Company. The Company and the Designating Stockholder agree that the other Stockholder Indemnitors are express third-party beneficiaries of this Section 16(c). 

(d) Except as provided in paragraph (c) above, in the event of any payment under this Agreement, the Company shall be subrogated to the
extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring
suit to enforce such rights. 
 (e) Except as provided in paragraph (c) above, the Company shall not be liable under this Agreement to
make any payment of amounts otherwise indemnifiable (or for which advancement is provided hereunder) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract or agreement of or
with the Company. 

  
 -15- 

 (f) The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is
or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or
other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other corporation, limited liability company, partnership, joint venture, trust or other enterprise. 

Section 17. Duration of Agreement. This Agreement shall continue until and terminate upon the later of: (a) ten
(10) years after the date that Indemnitee shall have ceased to serve as a director of the Company or (b) one (1) year after the final termination of any Proceeding then pending in respect of which Indemnitee is granted rights of
indemnification or advancement of Expenses hereunder and of any proceeding commenced (including any appeal thereof) by Indemnitee pursuant to Section 15 of this Agreement relating thereto. The indemnification and advancement of expenses rights
provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto, the Designating Stockholder and their respective successors and assigns (including any direct or indirect successor by purchase,
merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise, and
shall inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives. The Company shall require and shall cause any successor (whether direct or indirect by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company to, by written agreement, expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would
be required to perform if no such succession had taken place. 
 Section 18. Severability. If any provision or provisions of
this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any
Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the
fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest
extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or
unenforceable) shall be construed so as to give effect to the intent manifested thereby. 
 Section 19. Enforcement. 

(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in
order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company. 

  
 -16- 

 (b) This Agreement constitutes the entire agreement between the parties hereto with respect to
the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in
furtherance of the Certificate of Incorporation, the By-laws, any directors’ and officers’ insurance maintained by the Company and applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of
Indemnitee thereunder. 
 Section 20. Modification and Waiver. No supplement, modification or amendment of this Agreement shall
be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing
waiver. 
 Section 21. Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with
any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify
the Company shall not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or otherwise. 

Section 22. Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be
deemed to have been duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, (b) mailed by certified or registered mail with postage prepaid, on the third
business day after the date on which it is so mailed, (c) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have been directed or (d) sent by facsimile transmission, with
receipt of oral confirmation that such transmission has been received: 
 (a) If to Indemnitee, at the address indicated on the signature
page of this Agreement, or such other address as Indemnitee shall provide to the Company. 
 (b) If to the Company to 

Virgin America Inc. 
 555 Airport
Blvd., Suite 500 
 Burlingame, CA 94010 

Attention: General Counsel 
 Tel:
650-762-7108 
 or to any other address as may have been furnished to Indemnitee by the Company. 

  
 -17- 

 Section 23. Contribution. To the fullest extent permissible under applicable law, if
the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by or on behalf of Indemnitee, whether for judgments,
fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all
of the circumstances of such Proceeding in order to reflect the relative benefits received by the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined
in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction or events from which such Proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the
extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors or employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in
such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the transaction or events that resulted in such Expenses, judgments, fines, penalties, excise taxes or settlement amounts, as well as any other
equitable considerations which applicable law may require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if
joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions were motivated by intent to gain personal profit or advantage,
the degree to which their liability is primary or secondary and the degree to which their conduct is passive or active. 
 Section 24.
Applicable Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of
laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out
of or in connection with this Agreement shall be brought only in the Court of Chancery of the State of Delaware (the “Delaware Court”), and not in any other state or federal court in the United States of America or any court in any other
country, (ii) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) appoint, to the extent such party is not otherwise
subject to service of process in the State of Delaware, irrevocably RL&F Service Corp., 920 North King Street, 2nd Floor, Wilmington, New Castle County, Delaware 19801 as its agent in the
State of Delaware as such party’s agent for acceptance of legal process in connection with any such action or proceeding against such party with the same legal force and validity as if served upon such party personally within the State of
Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court
has been brought in an improper or inconvenient forum. 

  
 -18- 

 Section 25. Identical Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be
produced to evidence the existence of this Agreement. 
 Section 26. Third-Party Beneficiaries. The Designating Stockholders and
their respective affiliates are express third-party beneficiaries of this Agreement, are entitled to rely upon this Agreement and may specifically enforce the Company’s obligations hereunder (including but not limited to the obligations
specified in Section 6 of this Agreement). 
 Section 27. Miscellaneous. Use of the masculine pronoun shall be deemed to
include usage of the feminine pronoun where appropriate. The headings of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. 

IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year first above written. 

 

									
	VIRGIN AMERICA INC.	 		 	INDEMNITEE
				
	By:	 	  
	 		 	  

	Name:	 		 		 	Name:	 	
	Office:	 		 		 	Address:	 	  

		 		 		 		 	  

		 		 		 		 	  

  
 -19-EX-10.46

 Exhibit 10.46 

RECAPITALIZATION AGREEMENT 

dated as of                  , 2014 

by and among 
 VIRGIN AMERICA
INC., 
 VIRGIN MANAGEMENT LIMITED, 

VA HOLDINGS (GUERNSEY) LP, 

VX HOLDINGS, L.P., 

VIRGIN HOLDINGS LIMITED, 

CYRUS SELECT OPPORTUNITIES MASTER 

FUND, LTD., 
 CYR FUND,
L.P., 
 CRESCENT 1, L.P., 

CYRUS OPPORTUNITIES MASTER FUND II, LTD., 

CYRUS AVIATION INVESTOR, LLC, 

CYRUS AVIATION PARTNERS III, L.P., 

CYRUS AVIATION PARTNERS IIIA, L.P., 

CYRUS AVIATION PARTNERS IV, L.P., 

CM FINANCE INC, 
 CCP
INVESTMENTS I, L.P., and 
 CRS FUND, LTD. 

CYRUS AVIATION HOLDINGS, LLC, and 

VAI MBO INVESTORS LLC 

 TABLE OF CONTENTS 

 

									
	 	    	 	    	 	  	Page	 
			
	 1.
	    	 Definitions
	  	 	4	  
	 2.
	    	 Retained Proceeds
	  	 	10	  
	 3.
	    	 Treatment of Notes
	  	 	10	  
		    	3.1	    	 Cash Repayment of Repayment Notes
	  	 	10	  
		    	3.2	    	 Exchange of Premium Notes for Common Stock
	  	 	11	  
		    	3.3	    	 Exchange of Exchange Notes for the Virgin Group Post-IPO Note
	  	 	12	  
		    	3.4	    	 Exchange of Remaining Notes for Shares of Common Stock or Post-IPO Penny Warrants
	  	 	12	  
	 4.
	    	 Treatment of Warrants
	  	 	13	  
		    	4.1	    	 Exchange of Exchange Warrants for Shares of Common Stock or Post-IPO Penny Warrants
	  	 	13	  
		    	4.2	    	 Cancellation of Cancellation Warrants
	  	 	13	  
	 5.
	    	 Treatment of Capital Stock
	  	 	13	  
		    	5.1	    	 Exchange of Preferred Stock for Shares of Common Stock or Post-IPO Penny Warrants
	  	 	13	  
		    	5.2	    	 Automatic Conversion of Pre-IPO Common Stock
	  	 	13	  
	 6.
	    	 Allocation
	  	 	14	  
	 7.
	    	 Compliance with Federal Aviation Laws
	  	 	14	  
	 8.
	    	 Underwriters’ Overallotment in Initial Public Offering
	  	 	15	  
	 9.
	    	 Cooperation
	  	 	15	  
		    	9.1	    	 Amendments to Certificate of Incorporation
	  	 	15	  
		    	9.2	    	 Reimbursement Agreement
	  	 	15	  
		    	9.3	    	 Registration Rights Agreement
	  	 	16	  
		    	9.4	    	 Amended and Restated Virgin License
	  	 	16	  
		    	9.5	    	 Cyrus Recapitalization
	  	 	16	  
		    	9.6	    	 No Transfer of Securities
	  	 	16	  
		    	9.7	    	 Conflicts with Pre-IPO Transaction Documents
	  	 	16	  
		    	9.8	    	 Termination of Security Agreements and Intercreditor Agreement
	  	 	16	  
		    	9.9	    	 HSR Matters
	  	 	16	  
		    	9.10	    	 DOT Matters
	  	 	16	  
		    	9.11	    	 Voting and Cooperation
	  	 	17	  
	 10.
	    	 Representations and Warranties of the Company
	  	 	17	  
		    	10.1	    	 Organization; Powers
	  	 	17	  
		    	10.2	    	 Authorization; Enforceability
	  	 	17	  
		    	10.3	    	 Consents and Approvals; No Conflicts
	  	 	17	  
	 11.
	    	 Representations and Warranties of the Equityholders
	  	 	17	  
		    	11.1	    	 Authorization; Enforceability
	  	 	17	  
		    	11.2	    	 Compliance with Governmental Requirements and Other Instruments
	  	 	18	  
		    	11.3	    	 Acquisition for the Account of Each Equityholder
	  	 	18	  
		    	11.4	    	 Common Stock Not Registered
	  	 	18	  
		    	11.5	    	 Additional Acknowledgements
	  	 	18	  
		    	11.6	    	 Accredited Investor
	  	 	19	  
		    	11.7	    	 Economic Risk
	  	 	19	  
		    	11.8	    	 Rule 144
	  	 	19	  
		    	11.9	    	 Ownership of Securities
	  	 	19	  

  
 i 

									
	 12.
	    	 Miscellaneous
	  	 	19	  
		    	12.1	    	 Waivers and Amendments
	  	 	19	  
		    	12.2	    	 Notices
	  	 	19	  
		    	12.3	    	 Governing Law
	  	 	20	  
		    	12.4	    	 Waiver of Jury Trial, Punitive Damages, Etc.
	  	 	20	  
		    	12.5	    	 Entire Agreement
	  	 	20	  
		    	12.6	    	 Assignment; Successors and Assigns
	  	 	21	  
		    	12.7	    	 Counterparts
	  	 	21	  
		    	12.8	    	 Severability
	  	 	21	  
		    	12.9	    	 Specific Performance
	  	 	21	  
		    	12.10	    	 Further Assurances
	  	 	21	  
		    	12.11	    	 Restrictive Legends
	  	 	22	  
		    	12.12	    	 Withholding
	  	 	22	  
		    	12.13	    	 Effectiveness
	  	 	22	  
		    	12.14	    	 Interpretation
	  	 	22	  

 Schedules and Exhibits 
  

			
	Schedule A	    	ONPA Notes
	Schedule B	    	ANPA Notes
	Schedule C	    	TNPA Notes
	Schedule D	    	Fourth NPA Notes
	Schedule E	    	Fifth NPA Notes
	Schedule F	    	Related-Party Pre-IPO Warrants
		
	Exhibit A	    	Form of Virgin Group Post-IPO NPA
	Exhibit B	    	Form of Reimbursement Agreement
	Exhibit C	    	Form of Registration Rights Agreement
	Exhibit D	    	Form of Amended and Restated Virgin License

  
 ii 

 Exhibit 10.46 

RECAPITALIZATION AGREEMENT 

THIS RECAPITALIZATION AGREEMENT (this “Agreement”) is dated as of
                 , 2014, and is being entered into by and among Virgin America Inc., a Delaware corporation (the “Company”); Virgin Management Limited,
a limited liability company organized under the laws of England and Wales (“VML”); VX Holdings, L.P., a Delaware limited partnership (“VXH”); VA Holdings (Guernsey) LP, a Guernsey limited partnership
(“VAHG”); Virgin Holdings Limited, a limited liability company organized under the laws of England and Wales (“VHL” and together with VXH, VML and VXH, the “Virgin Group”); Cyrus Select
Opportunities Master Fund, Ltd., a limited company based in the Cayman Islands (“CSOM”); CYR Fund, L.P., a Delaware limited partnership (“CYR”); Crescent 1, L.P., a Delaware limited partnership
(“Crescent”); Cyrus Opportunities Master Fund II, Ltd., a limited company based in the Cayman Islands (“COM”); Cyrus Aviation Investor, LLC (“Investor LLC”); Cyrus Aviation Partners III, L.P., a
Delaware limited partnership. (“CAP III”); Cyrus Aviation Partners IIIA, L.P., a Delaware limited partnership (“CAP IIIA”); Cyrus Aviation Partners IV, L.P., a Delaware limited partnership (“CAP
IV”); CCP Investments I, L.P., a Delaware limited partnership (“CCP”); CM Finance Inc, a Maryland corporation (“CMF”); CRS Fund, Ltd., a limited company based in the Cayman Islands (“CRS,”
and collectively with CSOM, CYR, Crescent, COM, Investor LLC, CAP III, CAP IIIA, CAP IV, CCP and CMF, the “Cyrus Parties”); Cyrus Aviation Holdings, LLC (“Cyrus Holdings”); and VAI MBO Investors, LLC, a Delaware
limited liability company (“MBO”). 
 RECITALS 

WHEREAS, the Company, VML and VAHG are parties to that certain Note Purchase Agreement, dated as of April 15, 2008, as amended by
Amendment No. 1 to the Note Purchase Agreement, dated as of July 6, 2008, as amended and restated as of November 3, 2008, as further amended by Amendment No. 1 to the Original Note Purchase Agreement, dated as of January 12,
2010, as further amended and restated as of December 9, 2011, and as further amended by that certain Amendment No. 1 to Second Amended and Restated Note Purchase Agreement, dated May 10, 2013 (the “Original NPA”)
pursuant to which the Company issued certain notes, which notes are currently held by the Equityholders reflected on Schedule A hereto (the “ONPA Notes”). 

WHEREAS, the Company, VML, VAHG, COM, CRS, Crescent and CSOM are party to that certain Additional Note Purchase Agreement, dated
November 3, 2008, as amended and restated as of January 12, 2010, and as amended to date, as further amended and restated as of December 9, 2011, and as further amended by that certain Amendment No. 1 to Second Amended and
Restated Additional Note Purchase Agreement, dated May 10, 2013 (the “Additional NPA”) pursuant to which the Company issued certain notes, which notes are currently held by the Equityholders reflected on Schedule B
hereto (the “ANPA Notes”). 
 WHEREAS, the Company, VML, VAHG, COM, CRS, Crescent and CSOM are party to that certain
Third Note Purchase Agreement, dated January 12, 2010, as amended and restated as of December 9, 2011, and as further amended by that certain Amendment No. 1 to the Amended and Restated Third Note Purchase Agreement, dated
May 10, 2013 (the “Third NPA”) pursuant to which the Company issued certain notes, which notes are currently held by the Equityholders reflected on Schedule C hereto (the “TNPA Notes”). 

 WHEREAS, the Company, VML, COM, CYR, Crescent, CSOM and CAP III are party to that certain
Fourth Note Purchase Agreement, dated December 9, 2011, as amended by that certain Amendment No. 1 to the Fourth Note Purchase Agreement, dated May 10, 2013 (the “Fourth NPA”) pursuant to which the Company issued
certain notes, which notes are currently held by the Equityholders reflected on Schedule D hereto (the “Fourth NPA Notes”). 

WHEREAS, on May 10, 2013, VML transferred all of the Fourth NPA Notes owned by it to CAP IIIA, CMF, COM and CCP. 

WHEREAS, the Company, VML, COM, CAP IV and CMF are party to that certain Fifth Note Purchase Agreement, dated May 10, 2013 (the
“Fifth NPA,” and collectively with the ONPA, the ANPA, the TNPA and the Fourth NPA, the “Note Purchase Agreements”) pursuant to which the Company issued certain notes, which notes are currently held by the
Equityholders reflected on Schedule E hereto (the “Fifth NPA Notes”). 
 WHEREAS, the obligations of the
Company under each of the Note Purchase Agreements are secured by substantially all of the assets of the Company pursuant to the terms of certain security agreements (collectively, the “Security Agreements”). 

WHEREAS, the Company, VML, VAHG, COM, CYR, Crescent, CSOM, CAP III, CRS, CAP IV and CMF are party to that certain Intercreditor
Agreement, dated December 9, 2011, as amended and restated as of May 10, 2013 (the “Intercreditor Agreement”), which details the relative rights of the various parties under the Note Purchase Agreements and the Security
Agreements with respect to the ONPA Notes, the ANPA Notes, the TNPA Notes, the Fourth NPA Notes and the Fifth NPA Notes (collectively, the “Notes”). 

WHEREAS, in connection with the Note Purchase Agreements and certain other transactions, the Company issued certain warrants to
purchase shares of Capital Stock (as defined below) of the Company, which are currently held (i) by the Virgin Group in the amounts and at the exercise prices set forth on Schedule F hereto (the “Virgin Group Pre-IPO
Warrants”); (ii) by the Cyrus Parties in the amounts and at the exercise prices set forth on Schedule F hereto (the “Cyrus Party Pre-IPO Warrants”); and (iii) by MBO in the amounts and at the exercise
prices set forth on Schedule F hereto (the “MBO Pre-IPO Warrants,” and collectively with the Virgin Group Pre-IPO Warrants and the Cyrus Party Pre-IPO Warrants, the “Related-Party Pre-IPO Warrants”). 

WHEREAS, the Company previously has issued to certain individuals not party to this Agreement certain other warrants to purchase shares
of Capital Stock of the Company (the “Third-Party Pre-IPO Warrants”), which shall expire if unexercised upon the consummation of the Initial Public Offering (as defined below). 

WHEREAS, immediately prior to the VAI Distributions (as defined below), (i) VAI Partners LLC, a Delaware limited liability company
(“VAI”), held an aggregate of 1,874,474 shares of Class A Common Stock, 220,000 shares of Class A-1 Common Stock and 8,377,895 shares of Preferred Stock (collectively, the “VAI Securities”) and
(ii) VAI Management, LLC (“VAI Manager”) held certain Related-Party Pre-IPO Warrants. 

  
 2 

 WHEREAS, prior to the Recapitalization (as defined below), (i) VAI distributed all of
the VAI Securities to Investor LLC, VX Employee Holdings, LLC, MBO and VAI Manager, and (ii) VAI Manager distributed all of the Related-Party Pre-IPO Warrants held by it and all of the VAI Securities that it received from VAI to Investor LLC
and MBO (the “VAI Distributions”). 
 WHEREAS, notwithstanding anything to the contrary in the Note Purchase
Agreements, the Security Agreements, the Intercreditor Agreement or the Related-Party Pre-IPO Warrants (collectively, the “Pre-IPO Transaction Documents”), in connection with and in order to facilitate the consummation by the
Company of the sale of shares of its Capital Stock made effective pursuant to the Securities Act of 1933, as amended (the “Securities Act”) pursuant to a firm underwritten public offering registered on a registration statement on
Form S-1 (or any successor thereto) (the “Initial Public Offering”), and subject to any filings required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), and the related
expiration or early termination of any required waiting period thereunder, the parties hereto wish to provide for the following (collectively, the “Recapitalization”): (i) the Company shall retain the Retained Proceeds (as
defined below) for purposes of liquidity; (ii) Restricted Cash Amount (as defined below) and an amount of Net Proceeds (as defined below) from the Initial Public Offering equal to the Recapitalization Proceeds (as defined below) shall be used
by the Company to repay accrued and unpaid (by way of PIK or otherwise) interest on and the aggregate principal amount of the Repayment Notes (as defined below); (iii) accrued and unpaid (by way of PIK or otherwise) interest on and the
aggregate principal amount of all Premium Notes (as defined below) shall be exchanged for either shares of Common Stock at a price per share equal to the Premium Conversion Price (as defined below); (iv) the Exchange Notes (as defined below)
shall be exchanged for the Virgin Group Post-IPO Note (as defined below); (v) accrued and unpaid (by way of PIK or otherwise) interest on and the aggregate principal amount of the Remaining Notes (as defined below) shall be exchanged for either
shares of Common Stock at a price per share equal to the Offering Price (as defined below) or certain Post-IPO Penny Warrants (as defined below) as provided for herein; (vi) each Exchange Warrant (as defined below) shall be exchanged for either
shares of Common Stock at a price per share equal to the Offering Price or Post-IPO Penny Warrants as provided for herein; (vii) each Cancellation Warrant (as defined below) shall be cancelled in full; (viii) all outstanding shares of
Preferred Stock (as defined below) shall be exchanged for either shares of Common Stock at a price per share equal to the Offering Price or Post-IPO Penny Warrants as provided for herein; (ix) all outstanding shares of Non-Class-A Common Stock
held by parties to this Agreement shall be automatically converted into shares of Common Stock in accordance with the rights and privileges of such shares; and (x) each outstanding share of Class A Common Stock held by parties to this
Agreement shall be exchanged for one (1) share of Common Stock. 
 WHEREAS, immediately following the transactions contemplated
by Sections 3.2, 3.3, 3.4, 4 and 5 below and on the date of the Pricing (as defined below), each of the Cyrus Parties, other than CMF, will effect a transaction by which the securities of the Company will be held by Cyrus Holdings, with the effect
that no securities held by Cyrus Holdings will constitute Alien-Owned Shares (the “Cyrus Recapitalization”). 

  
 3 

 WHEREAS, immediately following the transactions contemplated by Sections 3.2, 3.3, 3.4, 4
and 5 below and prior to the consummation of the Initial Public Offering, the Company will file an amendment to its amended and restated certificate of incorporation (the “Pre-IPO Charter Amendment”) to effect a reverse stock split
whereby each             (the “Reverse Split Amount”) outstanding shares of Common Stock shall automatically be combined and converted into one share of Common Stock and
will pay in cash the fair value of each fractional share resulting from the Reverse Split. 
 WHEREAS, in connection with and in
order to facilitate the Initial Public Offering, and in order to give effect to the Recapitalization, the Company and each Equityholder hereby enter into this Agreement on the date hereof, which shall be the date on which the Board of Directors of
the Company or any pricing committee thereof sets the price per share of the Company’s Common Stock for the Initial Public Offering (the “Pricing”). 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the mutual promises, representations, warranties, covenants, conditions and agreements contained herein, and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the
parties hereto, intending to be legally bound by the terms hereof, hereby as follows: 
 1. Definitions. As used in this
Agreement, each capitalized term has the meaning ascribed to it in this Section 1: 
 “Additional NPA” shall
have the meaning ascribed to such term in the recitals hereto. 
 “Agreement” shall have the meaning ascribed to such term
in the preamble hereto, as amended from time to time. 
 “Alien-Owned” shall mean owned of record or owned beneficially, or
otherwise controlled, by any Person or Persons who is/are not United States Citizens. 
 “Amended and Restated Virgin
License” shall have the meaning ascribed to such term in Section 9.2. 
 “ANPA Notes” shall have the
meaning ascribed to such term in the recitals hereto. 
 “Business Day” shall mean any day that is not a Saturday, Sunday
or other day on which commercial banks in New York, New York or London, England are authorized or required by law to remain closed. 

“Business” shall mean the business of the Company as currently conducted. 

“CAP III” shall have the meaning ascribed to such term in the preamble hereto. 

“CAP IIIA” shall have the meaning ascribed to such term in the preamble hereto. 

  
 4 

 “CAP IV” shall have the meaning ascribed to such term in the preamble hereto.

 “Cancellation Warrants” shall have the meaning ascribed to such term in Section 4.2. 

“Capital Stock” shall mean the any capital stock of the Company. 

“CCP” shall have the meaning ascribed to such term in the preamble hereto. 

“Class A Common Stock” shall mean the Company’s Class A Common Stock, par value $0.01 per share, outstanding prior
to the Pricing. 
 “CMF” shall have the meaning ascribed to such term in the preamble hereto. 

“COM” shall have the meaning ascribed to such term in the preamble hereto. 

“Common Stock” shall mean, following the Pricing, the Non-Voting Common Stock and Voting Common Stock of the Company, or any
successor shares into which such Common Stock is exchanged or reclassified. 
 “Company” shall have the meaning ascribed to
such term in the preamble hereto. 
 “Crescent” shall have the meaning ascribed to such term in the preamble hereto. 

“CRS” shall have the meaning ascribed to such term in the preamble hereto. 

“CSOM” shall have the meaning ascribed to such term in the preamble hereto. 

“CYR” shall have the meaning ascribed to such term in the preamble hereto. 

“Cyrus Holdings” shall have the meaning ascribed to such term in the preamble hereto; 

“Cyrus Parties” shall have the meaning ascribed to such term in the preamble hereto. 

“Cyrus Party Pre-IPO Warrants” shall have the meaning ascribed to such term in the preamble hereto. 

“Cyrus Recapitalization” shall have the meaning ascribed to such term in the preamble hereto. 

“DOT” shall mean the U.S. Department of Transportation. 

“Employee LLC Proceeds” shall mean cash proceeds from the Initial Public Offering received by VX Employee Holdings, LLC, net
of all underwriter commissions, which proceeds will be remitted to the Company for distribution to certain of the Company’s employees. 

  
 5 

 “Equityholders” shall mean each of the Cyrus Parties, Cyrus Holdings, each party
in the Virgin Group and MBO. 
 “Exchange Notes” shall have the meaning ascribed to such term in
Section 3.3(a). 
 “Exchange Warrants” shall mean all Class A Warrants, Class C-2 Warrants, Class C-4
Warrants, Class C-11 Warrants, Class C-12 Warrants, Class C-14 Warrants and Class C-15 Warrants of the Company outstanding as of the Pricing, as reflected on Schedule F. 

“Federal Aviation Laws” shall mean the federal aviation laws codified in title 49 of the United States Code. 

“Fifth NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Fifth NPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“Fourth NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Fourth NPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“Governmental Authority” shall mean the government of the United States of America, any other nation or any political
subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or
pertaining to government. 
 “Governmental Requirement” shall mean any law, statute, code, ordinance, order, determination,
rule, regulation, judgment, decree, injunction, franchise, permit, certificate, license, authorization or other directive or requirement (whether or not having the force of law), including, without limitation, environmental laws, energy regulations
and occupational, safety and health standards or controls, of any Governmental Authority. 
 “Holdback Letter of Credit”
shall mean any standby letter of credit issued by Barclays Bank plc or one of its affiliates at the request of Virgin Group, and upon the terms and conditions agreed upon between the Company, Virgin Group and any LC Beneficiary, to be issued in
favor of any LC Beneficiary for the purpose of satisfying the Company’s cash holdback requirements for the Company’s air traffic liability set forth in agreements between the Company and such LC Beneficiary. 

“HSR Act” shall have the meaning ascribed to such term in the recitals hereto. 

“Initial Public Offering” shall have the meaning ascribed to such term in the recitals hereto. 

“Intercreditor Agreement” shall have the meaning ascribed to such term in the recitals hereto. 

  
 6 

 “Investor LLC” shall have the meaning ascribed to such term in the preamble
hereto; 
 “LC Beneficiary” shall mean each of U.S. Bank, National Association and America Express Travel Related Services
Company, Inc. 
 “LC Transaction” shall mean the establishment of one or more Holdback Letters of Credit for the purpose of
enabling the LC Beneficiaries to release an amount of cash equal to the Restricted Cash Amount from the holdback restrictions under the Company’s agreements with such LC Beneficiaries. 

“Lessor Obligations” shall mean an amount equal to $        , which represents
certain obligations owed by the Company to certain of its aircraft lessors in connection with previously negotiated reductions in aircraft rent expense. 

“Lien” shall mean, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, hypothecation, security
agreement, encumbrance, charge, option or security interest in, on or of such asset and (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having
substantially the same economic effect as any of the foregoing) relating to such asset. 
 “Material Adverse Effect” shall
mean any event, change or development, or combination of events, changes or developments, individually or in the aggregate, that has or would reasonably be expected to have a material adverse effect on the Business, results of operations, assets,
liabilities, operations, property, prospects or financial condition of the Company. 
 “MBO” shall have the meaning
ascribed to such term in the preamble hereto. 
 “MBO Pre-IPO Warrants” shall have the meaning ascribed to such term in the
preamble hereto. 
 “Net Proceeds” shall mean cash proceeds from the Initial Public Offering received by the Company, net
of, all underwriter commissions and estimated transaction expenses to be borne by Company. For the avoidance of any doubt, Net Proceeds shall not include any Employee LLC Proceeds. 

“Non-Class-A Common Stock” shall mean (a) the Company’s Class A-1 Common Stock, par value $0.01 per share;
(b) the Company’s Class B Common Stock, par value $0.01 per share; (c) the Company’s Class C Common Stock, par value $0.01 per share; (d) the Company’s Class D Common Stock, par value $0.01 per share; (e) the
Company’s Class F Common Stock, par value $0.01 per share; and (f) the Company’s Class G Common Stock, par value $0.01 per share, in each case, outstanding prior to the Pricing. 

“Non-Voting Common Stock” shall mean, following the Pricing, the non-voting common stock of the Company, par value $0.01 per
share, or any successor shares into which such Common Stock is exchanged or reclassified. 
 “Note Purchase Agreements”
shall have the meaning ascribed to such term in the recitals hereto. 

  
 7 

 “Notes” shall have the meaning ascribed to such term in the recitals hereto.

 “Offering Price” shall mean a price per share equal to the public offering price per share in the Initial Public
Offering divided by the Reverse Split Amount. 
 “ONPA Notes” shall have the meaning ascribed to such term in the recitals
hereto. 
 “Original NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“Overallotment Shares” shall mean have the meaning ascribed to such term in Section 8. 

“Person” shall mean any natural person, corporation, limited liability company, trust, joint venture, association, company,
partnership, Governmental Authority or other entity. 
 “Post-IPO Penny Warrants” shall mean warrants to purchase shares of
Common Stock at an exercise price of $0.01 per share with a term equal to thirty (30) years from the date of the Pricing. 

“Pricing” shall have the meaning ascribed to such term in the recitals hereto. 

“Pre-IPO Charter Amendment” shall have the meaning ascribed to such term in the recitals hereto. 

“Pre-IPO Common Stock” shall have the meaning ascribed to such term in Section 5.2. 

“Preferred Stock” shall mean the Company’s Convertible Preferred Stock, par value $0.01 per share, outstanding prior to
the Pricing. 
 “Preferred Stock Value” shall mean the product of (i) the total number of outstanding shares of
Preferred Stock and (ii) the Offering Price. 
 “Premium Conversion Price” shall mean a price per share equal to the
Offering Price divided by 1.17. 
 “Premium Notes” shall have the meaning ascribed to such term in
Section 3.2(a). 
 “Recapitalization” shall have the meaning ascribed to such term in the preamble hereto. 

“Recapitalization Proceeds” shall mean have the meaning ascribed to such term in Section 3.1(a). 

“Reimbursement Agreement” shall mean have the meaning ascribed to such term in Section 9.2. 

“Related-Party Pre-IPO Warrants” shall mean the Virgin Group Pre-IPO Warrants, the Cyrus Party Pre-IPO Warrants and the MBO
Pre-IPO Warrants. 

  
 8 

 “Remaining Notes” shall have the meaning ascribed to such term in
Section 3.4(a). 
 “Repayment Notes” shall have the meaning ascribed to such term in
Section 3.1(a). 
 “Requisite Equityholders” shall mean each of VXH and Cyrus Holdings. 

“Restricted Cash Amount” shall have the meaning ascribed to such term in Section 3.1(a). 

“Retained Proceeds” shall have the meaning ascribed to such term in Section 2. 

“Reverse Split Amount” shall have the meaning ascribed to such term in the preamble hereto. 

“Securities Act” shall have the meaning ascribed to such term in the recitals hereto. 

“Security Agreements” shall have the meaning ascribed to such term in the recitals hereto. 

“Third-Party Pre-IPO Warrants” shall have the meaning ascribed to such term in the preamble hereto. 

“Third NPA” shall have the meaning ascribed to such term in the recitals hereto. 

“TNPA Notes” shall have the meaning ascribed to such term in the recitals hereto. 

“UCC” means the Uniform Commercial Code as adopted in the States of New York and Florida, as from time to time amended. 

“United States Citizen” shall mean a “citizen of the United States,” as defined in 49 U.S.C.
Section 40102(a)(15), as in effect on the date in question, or any successor statute or regulation, as interpreted by the DOT in applicable precedent. 

“VAHG” shall have the meaning ascribed to such term in the preamble hereto. 

“VAI Manager” shall have the meaning ascribed to such term in the preamble hereto. 

“VHL” shall have the meaning ascribed to such term in the preamble hereto. 

“Virgin Group” shall have the meaning ascribed to such term in the preamble hereto. 

“Virgin Group Post-IPO Note” shall mean the new note to be issued by the Company pursuant to the Virgin Group Post-IPO NPA,
in the form attached as Exhibit A to the Virgin Group Post-IPO NPA. 

  
 9 

 “Virgin Group Post-IPO NPA” shall mean the Note Purchase Agreement to be entered
into between the Company and VML in the form attached hereto as Exhibit A. 
 “Virgin Group Pre-IPO Warrants” shall
have the meaning ascribed to such term in the preamble hereto. 
 “VML” shall have the meaning ascribed to such term in the
preamble hereto. 
 “Voting Common Stock” shall mean, following the Pricing, the voting common stock of the Company, par
value $0.01 per share, or any successor shares into which such Common Stock is exchanged or reclassified. 
 “VXH” shall
have the meaning ascribed to such term in the preamble hereto. 
 “Warrant Value” shall mean, (a) with respect to any
Exchange Warrant other than Class C-11 Warrants and Class C-12 Warrants, the product of (i) the difference of the Offering Price minus the exercise price per Exchange Warrant Share of such Exchange Warrant, as adjusted for any stock-splits or
recapitalizations pursuant to the terms thereof, multiplied by (ii) the number of Exchange Warrant Shares issuable upon exercise of such Exchange Warrant and (b) with respect to any Class C-11 Warrants or Class C-12 Warrants, the product
of (i) the difference of the Offering Price minus $2.50, as adjusted for any stock-splits or recapitalizations pursuant to the terms thereof, multiplied by (ii) the number of Exchange Warrant Shares issuable upon exercise of such Class
C-11 Warrants or Class C-12 Warrants. 
 2. Retained Proceeds. Notwithstanding any terms of this Agreement to the contrary, of
the Net Proceeds, the Company shall retain (i) the amount required, as determined by the Board of Directors of the Company immediately prior to the consummation of the Recapitalization, such that the Company’s cash and cash equivalents
immediately following the Initial Public Offering equal approximately twenty-seven percent (27%) of the Company’s total revenue for the preceding twelve months and (ii) an amount equal to the Lessor Obligations, which shall be in
addition to the amounts described in clause (i) (together, the “Retained Proceeds”). 
 3. Treatment of
Notes. 
 3.1 Cash Repayment of Repayment Notes. 

(a) The Company shall use the sum of (x) $100,000,000 (the “Restricted Cash Amount”) and (y) the balance of the
Net Proceeds after deducting the Retained Proceeds (the “Recapitalization Proceeds”) to pay the holders of the following Notes (the “Repayment Notes”), as follows: 

(i) At or prior to the closing of the Initial Public Offering, the Restricted Cash Amount shall be used to repay the accrued and unpaid (by
way of PIK or otherwise) interest and then outstanding principal amounts on certain of the ONPA Notes, ANPA Notes and/or TNPA Notes held by the Virgin Group and identified by the Virgin Group to the Company in writing no later than two business days
prior to the Pricing; 

  
 10 

 (ii) Immediately upon the closing of the Initial Public Offering, fifty percent (50%) of
the Recapitalization Proceeds shall be used to repay the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts on the Fourth NPA Notes held by the Cyrus Parties on a pro rata basis determined by the
principal amount of the Fourth NPA Notes held by each such entity; 
 (iii) Immediately upon the closing of the Initial Public Offering,
fifty percent (50%) of the Recapitalization Proceeds, or such lesser amount as may be required to repay the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts on the Fifth NPA Notes held by the
Virgin Group, shall be used to repay the accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts on the Fifth NPA Notes held by the Virgin Group on a pro rata basis determined by the principal amount of the
Fifth NPA Notes held by each such entity; 
 (iv) Immediately upon the closing of the Initial Public Offering, any remaining
Recapitalization Proceeds after giving effect to Sections 3.1(a)(ii)-(iii) above, shall be used to repay accrued and unpaid (by way of PIK or otherwise) interest and principal amounts on certain of the ONPA Notes, ANPA Notes and/or TNPA
Notes held by the Virgin Group and identified by the Virgin Group to the Company in writing no later than two business days prior to the Pricing. 

(b) Each holder of a Repayment Note expressly consents to the repayment of the Repayment Notes as set forth in this Section 3.1.

 3.2 Exchange of Premium Notes for Common Stock. 

(a) Substantially contemporaneously with the Pricing, any accrued and unpaid (by way of PIK or otherwise) interest and then outstanding
principal amounts of any Fourth NPA Notes and Fifth NPA Notes other than the Repayment Notes (the “Premium Notes”) shall be automatically exchanged and, effective upon such exchange, cancelled, and each holder of a Premium Note
forgives and extinguishes all indebtedness represented by such Premium Note, including any accrued and unpaid (by way of PIK or otherwise) interest thereon, and waives receipt of all amounts due and owing on the Premium Note, in exchange for a
number of shares of Voting Common Stock (rounded down to the nearest whole share) equal to the quotient of (i) all accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts of the Premium Notes held by a
particular holder of Premium Notes divided by (ii) Premium Conversion Price. 
 (b) Each holder of a Premium Note exchanged pursuant
to this Section 3.2 agrees to the cancellation and termination of all rights relating to the Premium Note upon the exchange of the Premium Note, whether or not the Premium Note has been surrendered. Notwithstanding the foregoing, each
holder of a Premium Note agrees to surrender, at or before the Pricing, such Premium Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably
satisfactory to the Company. 

  
 11 

 3.3 Exchange of Exchange Notes for the Virgin Group Post-IPO Note.

 (a) Substantially contemporaneously with the Pricing an outstanding principal amount of up to $50,000,000 of the TNPA Notes held by
the VML and not paid pursuant to Section 3.1 (the “Exchange Notes”), shall be exchanged for the Virgin Group Post-IPO Note of identical principal amount. 

(b) Each holder of an Exchange Note exchanged pursuant to this Section 3.3 agrees to the cancellation and termination of all
rights relating to the Exchange Note upon the exchange of the Exchange Note, whether or not the Exchange Note has been surrendered. Notwithstanding the foregoing, each holder of an Exchange Note agrees to surrender, at or before the Pricing, such
Exchange Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

3.4 Exchange of Remaining Notes for Shares of Common Stock or Post-IPO Penny Warrants. 

(a) Substantially contemporaneously with the Pricing, any accrued and unpaid (by way of PIK or otherwise) interest and then outstanding
principal amounts of all Notes other than the Repayment Notes, the Premium Notes and the Exchange Notes (collectively, the “Remaining Notes”) shall be automatically exchanged and, effective upon such exchange, cancelled, and each
holder of a Remaining Note forgives and extinguishes all indebtedness represented by such Remaining Note, including any accrued and unpaid (by way of PIK or otherwise) interest thereon, and waives receipt of all amounts due and owing on the
Remaining Note, in exchange for either (X) a number of shares of Voting Common Stock or Non-Voting Common Stock (each rounded down to the nearest whole share) equal to the quotient of (i) any accrued and unpaid (by way of PIK or otherwise)
interest and then outstanding principal amounts of the Remaining Notes held by a particular holder of Remaining Notes divided by (ii) the Offering Price or (Y) Post-IPO Penny Warrants exercisable for that number of shares of Common Stock
(rounded down to the nearest whole share) equal to the quotient of (i) any accrued and unpaid (by way of PIK or otherwise) interest and then outstanding principal amounts of the Remaining Notes held by a particular holder of Remaining Notes
divided by (ii) the difference of the Offering Price minus $0.01, or a combination thereof, in each case as further detailed in Section 7.  

(b) Each holder of a Remaining Note exchanged pursuant to this Section 3.4 agrees to the cancellation and termination of all
rights relating to the Remaining Note upon the exchange of the Remaining Note, whether or not the Remaining Note has been surrendered. Notwithstanding the foregoing, each holder of a Remaining Note agrees to surrender, at or before the Pricing, such
Remaining Note to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

  
 12 

 4. Treatment of Warrants. 

4.1 Exchange of Exchange Warrants for Shares of Common Stock or Post-IPO Penny Warrants. Substantially contemporaneously with
the Pricing, each Exchange Warrant shall be automatically cancelled and exchanged for either (X) a number of shares of Voting Common Stock or Non-Voting Common Stock (each rounded down to the nearest whole share) equal to the quotient of
(i) the Warrant Value of such Exchange Warrant divided by (ii) the Offering Price or (Y) Post-IPO Penny Warrants exercisable for that number of shares of Common Stock (rounded down to the nearest whole share) equal to the quotient of
(i) the Warrant Value divided by (ii) the difference of the Offering Price minus $0.01, or a combination thereof, in each case as further detailed in Section 7. Each Equityholder that holds an Exchange Warrant as of the Pricing
agrees to surrender, at or before the Pricing, such Exchange Warrant to the Company for exchange and cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the
Company. 
 4.2 Cancellation of Cancellation Warrants. Substantially contemporaneously with the Pricing, each Related-Party
Pre-IPO Warrant other than the Exchange Warrants (collectively, the “Cancellation Warrants”) shall be automatically cancelled in full. Each Equityholder that holds a Cancellation Warrant as of the Pricing agrees to surrender, at or
before the Pricing, such Cancellation Warrant to the Company for cancellation in connection herewith or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

5. Treatment of Capital Stock. 

5.1 Exchange of Preferred Stock for Shares of Common Stock or Post-IPO Penny Warrants. Substantially contemporaneously with the
Pricing, the total number of outstanding shares of Preferred Stock held by each Equityholder shall be automatically cancelled and exchanged for either (X) an equivalent number of shares of Voting Common Stock or Non-Voting Common Stock or
(Y) Post-IPO Penny Warrants exercisable for that number of shares of Common Stock (rounded down to the nearest whole share) equal to the quotient of (i) the Preferred Stock Value divided by (ii) the difference of the Offering Price
minus $0.01, or a combination thereof, in each case as further detailed in Section 7. Each Equityholder that holds shares of Preferred Stock as of the Pricing agrees to surrender, at or before the Pricing, the original stock certificates
representing such shares or to execute and deliver to the Company an affidavit of loss and indemnity reasonably satisfactory to the Company. 

5.2 Automatic Conversion of Pre-IPO Common Stock. Substantially contemporaneously with the Pricing, (a) all outstanding
shares of Non-Class-A Common Stock held by any Equityholder shall be automatically converted (without any further action by the holders thereof) into shares of Common Stock in accordance with the rights and privileges of such shares and
(b) each outstanding share of Class A Common Stock held by any Equityholder shall be automatically cancelled and exchanged for one (1) shares of Common Stock. Each Equityholder that holds shares of Non-Class-A Common Stock or
Class A Common Stock (collectively, the “Pre-IPO Common Stock”) as of the Pricing agrees to surrender, at or before the Pricing, the original stock certificates representing such shares or to execute and deliver to the Company
an affidavit of loss and indemnity reasonably satisfactory to the Company. 

  
 13 

 6. Allocation. For the avoidance of doubt, no later than two days prior to the
Pricing, the Company will deliver to the Equityholders in electronic format a model for the calculation of all securities issuable and payments to be made pursuant to the terms of this Agreement in relation to the Notes, the Related-Party Pre-IPO
Warrants, the Preferred Stock and the Pre-IPO Common Stock, after giving effect to the provisions of Section 7, and the parties hereto shall take all reasonable steps necessary to ensure that such model reflects the provisions of this
Agreement. Notwithstanding the foregoing and provided that the Company remains at all times a United States Citizen under the Federal Aviation Laws, upon written instruction delivered to the Company prior to the Pricing: 

(a) the Virgin Group shall have the right to specify among the Virgin Group entities the allocation of (i) the amount of the Restricted
Cash Amount and the Recapitalization Proceeds payable to the Virgin Group pursuant to Section 3.1; (ii) the shares of Voting Common Stock or Non-Voting Common Stock or Post-IPO Penny Warrants issuable to the Virgin Group pursuant to
Section 3.2, Section 3.4, Section 4.1 and Section 5.1, subject to the terms of Section 7; and (iii) the amount of the Exchange Notes to be exchanged and the Virgin Group Post-IPO Note
to be issued to the Virgin Group pursuant to Section 3.3; and 
 (b) the Cyrus Parties shall have the right to specify among
the such entities the allocation of (i) the amount of the Restricted Cash Amount and the Recapitalization Proceeds payable to the Cyrus Parties pursuant to Section 3.1; and (ii) the shares of Voting Common Stock, Non-Voting
Common Stock or Post-IPO Penny Warrants issuable to the Cyrus Parties pursuant to Section 3.2, Section 3.4, Section 4.1 and Section 5.1, subject to the terms of Section 7. 

7. Compliance with Federal Aviation Laws. 

(a) So that the Company can ensure that it remains at all times a United States Citizen under the Federal Aviation Laws, wherever
Section 3.2, Section 3.4, Section 4.1 and Section 5.1 of this Agreement provide for the issuance of either Voting Common Stock, Non-Voting Common Stock or Post-IPO Penny Warrants, or a combination
thereof, the securities so provided for shall be issued in the following manner: 
 (i) To the extent such securities when issued would not
constitute Alien-Owned shares, such securities shall be issued as shares of Voting Common Stock; 
 (ii) To the extent that (i) shares
of Voting Common Stock when issued would constitute Alien-Owned shares; and (ii) the issuance of such Voting Common Stock would not cause the aggregate amount of all outstanding Alien-Owned voting stock of the Company to represent more
than nineteen percent (19%) of the total outstanding voting stock of the Company, such securities shall be issued as shares of Voting Common Stock; 

(iii) To the extent that (i) shares of Voting Common Stock when issued would constitute Alien-Owned shares; (ii) the issuance of
Voting Common Stock would cause the aggregate amount of all outstanding Alien-Owned voting stock of the Company to represent more than nineteen percent (19%) of the total outstanding voting stock of the

  
 14 

 
Company; and (iii) the issuance of Non-Voting Common Stock would not cause the aggregate amount of all outstanding Alien-Owned stock of the Company to represent more than forty-four
percent (44%) of the total outstanding stock of the Company, such securities shall be issued as shares of Non-Voting Common Stock; and 

(iv) To the extent that (i) shares of Voting Common Stock when issued would constitute Alien-Owned shares; (ii) the issuance of
Voting Common Stock would cause the aggregate amount of all outstanding Alien-Owned voting stock of the Company to represent more than nineteen percent (19%) of the total outstanding voting stock of the Company; and (iii) the issuance of
Non-Voting Common Stock would cause the aggregate amount of all outstanding Alien-Owned stock of the Company to represent more than forty-four percent (44%) of the total outstanding stock of the Company, such securities shall be issued as
Post-IPO Penny Warrants. 
 (b) Following the Initial Public Offering, the rights of the Voting Common Stock and Non-Voting Common Stock
shall be set forth in the Company’s amended and restated certificate of incorporation and bylaws, each as in effect immediately following the closing of the Initial Public Offering and as amended from time to time. Pursuant to such governing
documents, the Company shall have the power to, and shall, convert any shares of Voting Common Stock, including any shares of Voting Common Stock issued pursuant to Section 3.2, Section 3.4, Section 4.1,
Section 5.1 and Section 5.2, into Non-Voting Common Stock to reduce the voting interest in the Company represented by Alien-Owned shares as set forth in further detail therein. 

8. Underwriters’ Overallotment in Initial Public Offering. Subject to compliance with any applicable legal requirements,
each of the parties to this Agreement hereby agrees that, the underwriting agreement to be entered into in connection with the Initial Public Offering shall provide that, if the underwriters of the Initial Public Offering determine to exercise their
right to purchase additional shares of Common Stock (“Overallotment Shares”) pursuant to an overallotment option between the Company and such underwriters, then fifty percent (50%) of the Overallotment Shares shall consist of
Common Stock held by the Virgin Group and fifty percent (50%) of the Overallotment Shares shall consist of Common Stock held by Cyrus Holdings and CMF, and each of the Virgin Group, Cyrus Holdings and CMF, respectively, shall be entitled to
retain the proceeds (net of underwriter discounts and commissions) from the sale of such shares. 
 9. Cooperation.

 9.1 Amendments to Certificate of Incorporation. The parties hereto shall take all reasonable steps necessary for the
filing of the Pre-IPO Charter Amendment immediately following the transactions contemplated by Sections 3.2, 3.3, 3.4, 4 and 5 and to amend, modify or waive the provisions of the Company’s certificate of incorporation further, to the extent
necessary, to provide for the transactions contemplated by this Agreement. 
 9.2 Reimbursement Agreement. The Company and the
Virgin Group shall take all reasonable steps necessary to effect the LC Transaction. Immediately upon the Closing of the Initial Public Offering, the Company and VHL shall execute and deliver that certain Letter of Credit Reimbursement Agreement in
the form attached hereto as Exhibit B (the “Reimbursement Agreement”). 

  
 15 

 9.3 Registration Rights Agreement. That certain Registration Rights Agreement in
the form attached hereto as Exhibit C (the “Registration Rights Agreement”) shall have been executed and delivered by each of the Company, Cyrus Holdings, CMF and each entity in the Virgin Group prior to the consummation of
the transactions contemplated by Section 3, Section 4 and Section 5. 
 9.4 Amended and Restated
Virgin License. That certain Amended and Restated Virgin America Trade Mark License in the form attached hereto as Exhibit D (the “Amended and Restated Virgin License”) shall have been executed and delivered by each
of the Company, Virgin Aviation TM Limited and Virgin Enterprises Limited prior to the consummation of the transactions contemplated by Section 3, Section 4 and Section 5. 

9.5 Cyrus Recapitalization. Each of the Cyrus Parties, other than CMF, and Cyrus Holdings hereby covenants and agrees that it
shall take all necessary actions to effect the Cyrus Recapitalization immediately following the transactions contemplated by Sections 3.2, 3.3, 3.4, 4 and 5 and on the date of the Pricing. 

9.6 No Transfer of Securities. Each Equityholder hereby covenants and agrees that it shall not transfer any Notes, Related-Party
Pre-IPO Warrants, Preferred Stock or Pre-IPO Common Stock held by it prior to the consummation of the transactions contemplated by Section 3, Section 4 and Section 5. 

9.7 Conflicts with Pre-IPO Transaction Documents. In the event of any conflict between the terms of this Agreement and any
Pre-IPO Transaction Document, the terms of this Agreement shall govern and control. 
 9.8 Termination of Security Agreements and
Intercreditor Agreement. Following the payments and exchanges set forth in Section 3, Section 4 and Section 5, the parties hereto shall terminate the Intercreditor Agreement, the Company’s Sixth
Amended and Restated Stockholders Agreement and the Security Agreements and any related financing statements made under the UCC, and each holder of Notes terminates, releases and discharges, without recourse, all of the Liens on any assets of the
Company created by the Notes. 
 9.9 HSR Matters. All filings required under the HSR Act shall have been made, and any
required waiting period thereunder shall have expired or been earlier terminated, prior to the consummation of any of the transactions contemplated by Section 3, Section 4 and Section 5. If any filings are
required by the HSR Act for any transactions contemplated by Section 3, Section 4 or Section 5, the Company will cooperate reasonably with the other parties hereto to prepare and make such filings and shall pay
for any reasonable out-of-pocket expenses of such parties made in connection with the preparation and filing of any filings required under the HSR Act. 

9.10 DOT Matters. All requirements imposed by the DOT shall have been satisfied prior to the consummation of any of the
transactions contemplated by Section 3, Section 4 and Section 5. If any filings are required by the DOT for any transactions contemplated by Section 3, Section 4 or Section 5,
the Company will cooperate reasonably with the other parties 

  
 16 

 
hereto to prepare and make such filings and shall pay for any reasonable out-of-pocket expenses of such parties made in connection with the preparation and filing of any filings required by the
DOT. 
 9.11 Voting and Cooperation. In order to facilitate the transactions contemplated by this Agreement, each Equityholder
hereby agrees to vote all of such Equityholder’s shares of Capital Stock in favor of any amendments, modifications or waivers of the Company’s certificate of incorporation, including the Pre-IPO Charter Amendment, in order to effect the
transactions contemplated by this Agreement. In addition, each Equityholder agrees to execute and deliver all related documentation and take such other action in support of the transactions as contemplated by this Agreement as shall be reasonably
requested by the Company. 
 10. Representations and Warranties of the Company. The Company hereby represents, warrants and
covenants to the Equityholders that, as of the date hereof, each of the following representations and warranties set forth below in this Section 10 is true and correct. 

10.1 Organization; Powers. The Company is duly organized, validly existing and in good standing under the laws of the
jurisdiction of its organization, has all requisite power and authority to carry on its Business, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect, is qualified
to do business in, and is in good standing in, every jurisdiction where such qualification is required. 
 10.2 Authorization;
Enforceability. This Agreement has been duly executed and delivered by the Company and constitutes a legal, valid and binding obligation of the Company, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

10.3 Consents and Approvals; No Conflicts. The transactions contemplated hereby (i) do not require any consent or approval
of, registration or filing with, or any other action by, any Governmental Authority or any other Person, except such as have been obtained or made and are in full force and effect, where failure to obtain such consent or approval would not
reasonably be expected to have a Material Adverse Effect or other than as may be required under the HSR Act, (ii) will not violate the certificate of incorporation or bylaws of the Company or any order of any Governmental Authority and
(iii) will not violate any material Governmental Requirement. 
 11. Representations and Warranties of the Equityholders.
Each Equityholder, severally and not jointly, hereby, represents, warrants and covenants to the Company, as of the date hereof, as follows: 

11.1 Authorization; Enforceability. Such Equityholder has been duly formed and is validly existing as a legal entity in good
standing under the laws of its jurisdiction of organization. Such Equityholder has full power and authority to execute and deliver this Agreement and to perform its obligations hereunder and to consummate the transactions contemplated hereby. The
execution and delivery by such Equityholder of this Agreement, and 

  
 17 

 
the performance of its obligations hereunder, have been duly and validly authorized by all necessary actions of such Equityholder. This Agreement and all other documents referenced herein
executed by such Equityholder have been duly and validly executed and delivered by such Equityholder and constitute the legal, valid and binding obligations of such Equityholder, enforceable against such Equityholder, in accordance with their terms,
subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

11.2 Compliance with Governmental Requirements and Other Instruments. The consummation of the transactions contemplated by this
Agreement and the execution, delivery and performance of the documents referenced herein to which such Equityholder is a party will not (i) contravene, result in any breach of, or constitute a default under, any charter or bylaws or other
organizational documents of such Equityholder, or material agreement or instrument to which such Equityholder is a party, (ii) conflict with or result in a breach of any of the terms, conditions or provisions of any order of any court,
arbitrator or Governmental Authority applicable to such Equityholder, or (iii) violate any provision of any statute or other rule or regulation of any Governmental Authority applicable to such Equityholder. 

11.3 Acquisition for the Account of Each Equityholder. Such Equityholder is acquiring and will acquire all securities to be
issued pursuant to this Agreement (and all securities issuable upon exercise or conversion thereof) (collectively, the “Securities”) for its own account, with no present intention of distributing or reselling such securities or any
part thereof in violation of applicable securities laws. Such Equityholder further represents that it does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation to any third person with
respect to any of the Securities to be received pursuant to this Agreement. 
 11.4 Common Stock Not Registered. Such
Equityholder acknowledges that the Securities to be received pursuant to this Agreement have not been, and when issued will not be, registered under the Securities Act or the securities laws of any state in the United States or any other
jurisdiction and may not be offered or sold by such Equityholder unless subsequently registered under the Securities Act (if applicable to the transaction) and any other securities laws or unless exemptions from the registration or other
requirements of the Securities Act and any other securities laws are available for the transaction. 
 11.5 Additional
Acknowledgements. Such Equityholder has received and reviewed information about the Company and has had an opportunity to discuss the Company’s business, management and financial affairs with directors, officers and management of the
Company and to review the Company’s operations and facilities. Such Equityholder has also had the opportunity to ask questions of and receive answers from, the Company and its management regarding the terms and conditions the transactions
contemplated by this Agreement. Such Equityholder believes it has received all the information it considers necessary or appropriate to determine whether to receive the Securities as contemplated by this Agreement. Such Equityholder understands and
acknowledges that such discussions, as well as any written information issued by the Company may have contained forward-looking statements involving 

  
 18 

 
known and unknown risks and uncertainties which may cause the Company’s actual results in future periods or plans for future periods to differ materially from what was anticipated and that
no representations or warranties were or are being made with respect to any such forward-looking statements or the probability of achieving any of the results projected in any of such forward-looking statements. 

11.6 Accredited Investor. Such Equityholder represents that it is an “accredited investor” within the meaning of Rule
501 of Regulation D promulgated under the Securities Act, as presently in effect. 
 11.7 Economic Risk. Such Equityholder has
substantial experience in evaluating and investing in securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in the Company, has the capacity to protect its own interests and has the
ability to bear the economic risks of such Equityholder’s investment. Such Equityholder must bear the economic risk of this investment indefinitely unless the Securities are registered pursuant to the Securities Act, or an exemption from
registration is available. 
 11.8 Rule 144. Such Equityholder acknowledges and agrees that the Securities received pursuant
to this Agreement must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Such Equityholder has been advised or is aware of the provisions of Rule 144
promulgated under the Securities Act as in effect from time to time, which permits limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other things: the availability of
certain current public information about the Company, the resale occurring following the required holding period under Rule 144 and the number of shares being sold during any three-month period not exceeding specified limitations. Such Equityholder
understands that no public market now exists for any of the Securities issued by the Company pursuant to this Agreement and that a public market may never exist for the Company’s Capital Stock. 

11.9 Ownership of Securities. Such Equityholder is the sole beneficial and record owner of the Notes, the Related-Party Pre-IPO
Warrants, the Preferred Stock and the Pre-IPO Common Stock set forth on Schedules A through F attached hereto and has good, clear and marketable title to such securities, free of any Liens. 

12. Miscellaneous. 

12.1 Waivers and Amendments. Except as otherwise provided herein, no modification, amendment or waiver of any provision of this
Agreement shall be effective against the Company or the Equityholders unless such modification, amendment or waiver is approved in writing by the Company and the Requisite Equityholders. Any such modification, amendment or waiver given by the
Requisite Equityholders, as applicable, in accordance with this Section 12.1 shall be binding on all Equityholders. 
 12.2
Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified; (b) 

  
 19 

 
when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next Business Day; (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid; or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the parties at
their respective addresses as set forth on the signature pages hereof or at such other address as a given party may designate by ten days’ advance written notice to the other parties hereto. 

12.3 Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF
DELAWARE, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY SUBMITS ITSELF AND EACH OTHER RELATED PERSON TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE STATE
OF DELAWARE AND AGREES AND CONSENTS THAT SERVICE OF PROCESS MAY BE MADE UPON IT IN ANY LEGAL PROCEEDING RELATING TO THE THIS AGREEMENT. EACH OF THE PARTIES HERE IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION
THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH PROCEEDING BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. 

12.4 Waiver of Jury Trial, Punitive Damages, Etc. Each party hereto hereby: 

(a) KNOWINGLY, VOLUNTARILY, INTENTIONALLY, AND IRREVOCABLY WAIVES, TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW, ANY RIGHT IT MAY
HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR DIRECTLY OR INDIRECTLY AT ANY TIME ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR TRANSACTIONS CONTEMPLATED HEREBY OR ASSOCIATED HEREWITH, BEFORE OR AFTER MATURITY;

 (b) CERTIFIES THAT NO PARTY HERETO NOR ANY REPRESENTATIVE OR AGENT OR COUNSEL FOR ANY PARTY HERETO HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, OR IMPLIED THAT SUCH PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVERS; AND 

(c) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY BY, AMONG OTHER
THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS CONTAINED IN THIS SECTION. 
 12.5 Entire Agreement. This Agreement and the
documents and exhibits referenced herein sets forth the entire understanding of the parties hereto with respect to the 

  
 20 

 
subject matter hereof. There are no agreements, representations, warranties, covenants or understandings with respect to the subject matter hereof or thereof other than those expressly set forth
herein and therein. This Agreement supersedes all other prior agreements and understandings between the parties with respect to such subject matter. 

12.6 Assignment; Successors and Assigns. This Agreement shall be binding upon the parties hereto and their successors and
assigns and inure to the benefit of the parties hereto and their successors and assigns; provided, however, that the Company may not delegate or assign any of its obligations hereunder, and any purported delegation or assignment shall be void,
unless the Company has obtained the prior written consent of the Requisite Equityholders to such delegation or assignment, which consent the Requisite Equityholders may provide in their sole and absolute discretion. No Person, other than the parties
hereto and their permitted successors and assigns, shall have any rights hereunder or be entitled to rely on this Agreement and all third-party beneficiary rights are hereby expressly disclaimed. 

12.7 Counterparts. This Agreement and any amendment hereto may be signed in any number of separate counterparts, each of which
shall be deemed an original, but all of which taken together shall constitute one Agreement (or amendment, as applicable). Any signature page delivered electronically or by facsimile (including without limitation transmission by portable document
format or other fixed image form) shall be binding to the same extent as an original signature page. 
 12.8 Severability. In
the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and
of the remaining provisions contained herein shall not be affected or impaired thereby. 
 12.9 Specific Performance. The
parties hereto recognizes that money damages may be inadequate to compensate the other parties for a breach of its obligations hereunder, and the irrevocably agrees that the other parties shall be entitled to the remedy of specific performance or
the granting of such other equitable remedies as may be awarded by a court of competent jurisdiction in order to afford the parties to this Agreement the benefits of this Agreement and that each party shall not object and hereby waive any right to
object to such remedy or such granting of other equitable remedies on the grounds that money damages will be sufficient to compensate the parties hereto. 

12.10 Further Assurances. The parties hereto will sign such further documents, cause such meetings to be held, resolutions
passed, exercise their votes and do and perform and cause to be done such further acts and things necessary, proper or advisable in order to give full effect to this Agreement and every provision hereof. 

  
 21 

 12.11 Restrictive Legends. Each certificate representing Common Stock issued in
connection with this Agreement shall be stamped or otherwise imprinted with a legend substantially in the following form: 
 THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD,
MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933 AND APPLICABLE STATE SECURITIES LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM THE
REGISTRATION PROVISIONS OF THE SECURITIES ACT OF 1933 AND APPLICABLE STATE SECURITIES LAWS. 
 THE SECURITIES REPRESENTED BY THIS
CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT OF A PUBLIC OFFERING PURSUANT TO AN AGREEMENT, COPIES OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE COMPANY. SUCH LOCKUP PERIOD
IS BINDING ON TRANSFEREES OF THESE SECURITIES. 
 12.12 Withholding. To the extent necessary, the Company shall be entitled to
deduct and withhold from any amounts payable to an Equityholder pursuant to this Agreement, such amounts as the Company is required to deduct and withhold under the Internal Revenue Code of 1986, as amended, or any provision of state, local or
foreign tax law with respect to this Agreement. To the extent that amounts are so withheld and paid over to the appropriate Governmental Authority by the Company, such withheld amounts shall be treated for all purposes of this Agreement as having
been paid to the Equityholder in respect of whom such withholding was made. The Company shall provide evidence of such payment to such Equityholder. 

12.13 Effectiveness. This Agreement shall become effective on the date hereof. Unless otherwise agreed to be the Requisite
Equityholders, if the Initial Public Offering is not consummated on or prior to March 31, 2015, then this Agreement shall automatically terminate and be of no force and effect. 

12.14 Interpretation. In this Agreement, unless otherwise indicated, the singular includes the plural and conversely; words
importing one gender include the others; references to statutes or regulations are to be construed as including all statutory or regulatory provisions consolidating, amending or replacing the statute or regulation referred to; references to
“writing” include printing, typing, lithography and other means of reproducing words in a tangible visible form; the word “or” shall not be exclusive (i.e., shall be deemed to include “and/or”); the words
“including,” “includes” and “include” shall be deemed to be followed by the words “without limitation”; references to articles, sections (or subdivisions of sections), exhibits, annexes or schedules are to
such parts of this Agreement; references to agreements and other contractual instruments shall be deemed to include all subsequent amendments, restatements, amendments and restatements, supplements, extensions and other modifications to such
instruments (without, however, limiting any prohibition on any such amendments, extensions and other modifications by the terms of this Agreement); and references to Persons include their respective permitted successors and assigns and, in the case
of any Governmental Authority, Persons succeeding to their respective functions and capacities. 
 (Signature Pages Follow) 

  
 22 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	VIRGIN AMERICA INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	Address:
		 	555 Airport Blvd.
		 	Burlingame, CA 94010
		 	Facsimile: (650) 762-7001
		 	Attention: General Counsel

 [SIGNATURE PAGE TO RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	VIRGIN MANAGEMENT LIMITED
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	VX HOLDINGS, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	VA HOLDINGS (GUERNSEY) LP
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	VIRGIN HOLDINGS LIMITED
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	CYRUS SELECT OPPORTUNITIES MASTER FUND, LTD.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CYR FUND, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CRESCENT 1, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CYRUS OPPORTUNITIES MASTER FUND II, LTD.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CYRUS AVIATION INVESTOR, LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	CYRUS AVIATION PARTNERS III, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CYRUS AVIATION PARTNERS IIIA, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CYRUS AVIATION PARTNERS IV, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CCP INVESTMENTS I, L.P.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	CRS FUND, LTD.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	CM FINANCE INC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	CYRUS AVIATION HOLDINGS, LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed in its
name by its duly authorized officer as of the date set forth above. 
  

			
	VAI MBO INVESTORS, LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 [SIGNATURE PAGE TO
RECAPITALIZATION AGREEMENT] 

 Schedule A 

ONPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 VA Holdings (Guernsey) LP
	  	$	182,439,078.34	  

 Schedule B 

ANPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 VA Holdings (Guernsey) LP
	  	$	92,588,299.00	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	$	1,847,898.13	  
	 CYR Fund, L.P.
	  	$	3,880,586.08	  
	 Crescent 1, L.P.
	  	$	4,434,955.52	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	8,315,541.60	  

 Schedule C 

TNPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 VA Holdings (Guernsey) LP
	  	$	10,867,741.14	  
	 Virgin Management Limited
	  	$	59,357,903.48	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	2,437,106.73	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	$	541,579.27	  
	 CYR Fund, L.P.
	  	$	1,137,316.48	  
	 Crescent 1, L.P.
	  	$	1,299,790.26	  

 Schedule D 

Fourth NPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	19,018,838.00	  
	 CYR Fund, L.P.
	  	$	27,300,000.00	  
	 Crescent 1, L.P.
	  	$	24,600,000.00	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	$	2,790,000.00	  
	 Cyrus Aviation Partners III, L.P.
	  	$	53,740,631.00	  
	 CCP Investments I, L.P.
	  	$	759,369.00	  
	 Cyrus Aviation Partners IIIA, L.P.
	  	$	16,791,162.00	  
	 CM Finance LLC
	  	$	5,000,000.00	  

 Schedule E 

Fifth NPA Notes 
  

					
	 Equityholder
	  	Aggregate Face Amount	 
	 Cyrus Aviation Partners IV, L.P.
	  	$	23,160,421.00	  
	 CM Finance LLC
	  	$	5,000,000.00	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	$	9,339,579.00	  
	 Virgin Management Limited
	  	$	37,500,000.00	  

 Schedule F 

Related-Party Pre-IPO Warrants 

(without giving effect to the Reverse Stock Split to follow the Recapitalization) 

 

											
	 Equityholder
	  	Class	  	Shares	 	  	Exercise Price
per Share	 
	 Cyrus Aviation Investor, LLC
	  	A	  	 	334,837	  	  	$	0.01	  
	 VX Holdings, L.P.
	  	A	  	 	32,553	  	  	$	0.01	  
	 VAI MBO Investors, LLC
	  	A	  	 	167,418	  	  	$	0.01	  
	 VX Holdings, L.P.
	  	A	  	 	23,252	  	  	$	0.01	  
	 VX Holdings, L.P.
	  	C-2	  	 	1,346,065	  	  	$	0.01	  
	 VX Holdings, L.P.
	  	C-4	  	 	480,738	  	  	$	0.01	  
	 VX Holdings, L.P.
	  	C-5	  	 	60,000,000	  	  	$	5.00	  
	 Cyrus Aviation Investor LLC
	  	C-6	  	 	2,105,000	  	  	$	5.00	  
	 Cyrus Aviation Investor LLC
	  	C-7A	  	 	6,666,667	  	  	$	10.00	  
	 VAI MBO Investors, LLC
	  	C-7B	  	 	3,333,333	  	  	$	10.00	  
	 Cyrus Aviation Investor LLC
	  	C-8	  	 	20,000,000	  	  	$	15.00	  
	 Cyrus Aviation Investor LLC
	  	C-9	  	 	30,000,000	  	  	$	20.00	  
	 Cyrus Aviation Partners IIIA, L.P.
	  	C-11	  	 	1,292,919	  	  	$	3.50	  
	 CM Finance LLC
	  	C-11	  	 	385,000	  	  	$	3.50	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	C-11	  	 	247,081	  	  	$	3.50	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	C-12A	  	 	2,191,266	  	  	$	3.50	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	C-12B	  	 	386,694	  	  	$	3.50	  
	 CYR Fund, L.P.
	  	C-12C	  	 	3,783,780	  	  	$	3.50	  
	 Crescent 1, L.P.
	  	C-12D	  	 	3,409,560	  	  	$	3.50	  
	 Cyrus Aviation Partners III, L.P.
	  	C-12E	  	 	7,448,451	  	  	$	3.50	  
	 CCP Investments I, L.P.
	  	C-12E	  	 	105,249	  	  	$	3.50	  
	 Virgin Management Limited
	  	C-14A	  	 	14,539,414	  	  	$	2.50	  
	 VA Holdings (Guernsey) LP
	  	C-14B	  	 	140,916,026	  	  	$	2.50	  
	 VX Holdings, L.P.
	  	C-14C	  	 	7,446,931	  	  	$	0.01	  
	 Cyrus Opportunities Master Fund II, Ltd.
	  	C-15A	  	 	4,736,414	  	  	$	2.50	  
	 Cyrus Aviation Partners IV, L.P.
	  	C-15B	  	 	2,377,804	  	  	$	2.50	  
	 CM Finance LLC
	  	C-15C	  	 	513,333	  	  	$	2.50	  
	 Cyrus Select Opportunities Master Fund, Ltd.
	  	C-15D	  	 	839,456	  	  	$	2.50	  
	 CYR Fund, L.P.
	  	C-15E	  	 	1,762,857	  	  	$	2.50	  
	 Crescent 1, L.P.
	  	C-15F	  	 	2,014,694	  	  	$	2.50

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]